Dr. Brody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1190 5th Ave
New York, NY 10029Phone+1 212-241-6756Fax+1 212-423-0522
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
Yale-New Haven Medical CenterResidency, Internal Medicine, 2000 - 2003
Stony Brook University Health Sciences Center School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2003 - Present
NY State Medical License 2012 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma Start of enrollment: 2011 Feb 01
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers Start of enrollment: 2011 Oct 01
- In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy Start of enrollment: 2014 Jan 03
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle Kuhne, Torsten Trowe
Clinical Cancer Research. 2024-07-15 - 4 citationsSociety for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.Jason J Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody
Journal for Immunotherapy of Cancer. 2024-04-18 - 2 citationsT-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.Xiufen Chen, Jovian Yu, Girish Venkataraman, Sonali M Smith, Mengjie Chen
Cancer Immunology Research. 2024-03-04
Press Mentions
High-Dose Chemo, ASCT Improves Survival in Primary CNS LymphomaDecember 14th, 2022- Novel Vaccine Approach Halts Disease After 23 Years of Breast CancerDecember 10th, 2022
- Novel Vaccine Approach Halts Disease After 23 Years of Breast CancerNovember 18th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
